Limits...
Hyperbaric oxygen therapy for sudden sensorineural hearing loss after failure from oral and intratympanic corticosteroid.

Imsuwansri T, Poonsap P, Snidvongs K - Clin Exp Otorhinolaryngol (2012)

Bottom Line: Other treatments include vasodilator, immunosuppressant and antiviral medication.However, only 61% of patients achieve full recovery, and controversies about the standard treatment still exist.In this case report, we present a patient with idiopathic sudden sensorineural hearing loss who failed to respond to systemic and intratympanic steroid treatments but subsequently recovered after undergoing hyperbaric oxygen therapy.

View Article: PubMed Central - PubMed

Affiliation: Department of Ophthalmology and Otorhinolaryngology, Burapha University Faculty of Medicine, Chon Buri, Thailand.

ABSTRACT
Systemic and intratympanic steroids are most widely used for treating idiopathic sudden sensorineural hearing loss. Other treatments include vasodilator, immunosuppressant and antiviral medication. However, only 61% of patients achieve full recovery, and controversies about the standard treatment still exist. In this case report, we present a patient with idiopathic sudden sensorineural hearing loss who failed to respond to systemic and intratympanic steroid treatments but subsequently recovered after undergoing hyperbaric oxygen therapy.

No MeSH data available.


Related in: MedlinePlus

Hearing level (dB) by time course (week) showing the duration of each treatment. HBOT, hyperbaric oxygen therapy.
© Copyright Policy - open-access
Related In: Results  -  Collection

License
getmorefigures.php?uid=PMC3369993&req=5

Figure 5: Hearing level (dB) by time course (week) showing the duration of each treatment. HBOT, hyperbaric oxygen therapy.

Mentions: Audiograms and the time course are displayed in Figs. 4 and 5, respectively. No adverse events during or following HBOT and the intratympanic membrane injection were reported.


Hyperbaric oxygen therapy for sudden sensorineural hearing loss after failure from oral and intratympanic corticosteroid.

Imsuwansri T, Poonsap P, Snidvongs K - Clin Exp Otorhinolaryngol (2012)

Hearing level (dB) by time course (week) showing the duration of each treatment. HBOT, hyperbaric oxygen therapy.
© Copyright Policy - open-access
Related In: Results  -  Collection

License
Show All Figures
getmorefigures.php?uid=PMC3369993&req=5

Figure 5: Hearing level (dB) by time course (week) showing the duration of each treatment. HBOT, hyperbaric oxygen therapy.
Mentions: Audiograms and the time course are displayed in Figs. 4 and 5, respectively. No adverse events during or following HBOT and the intratympanic membrane injection were reported.

Bottom Line: Other treatments include vasodilator, immunosuppressant and antiviral medication.However, only 61% of patients achieve full recovery, and controversies about the standard treatment still exist.In this case report, we present a patient with idiopathic sudden sensorineural hearing loss who failed to respond to systemic and intratympanic steroid treatments but subsequently recovered after undergoing hyperbaric oxygen therapy.

View Article: PubMed Central - PubMed

Affiliation: Department of Ophthalmology and Otorhinolaryngology, Burapha University Faculty of Medicine, Chon Buri, Thailand.

ABSTRACT
Systemic and intratympanic steroids are most widely used for treating idiopathic sudden sensorineural hearing loss. Other treatments include vasodilator, immunosuppressant and antiviral medication. However, only 61% of patients achieve full recovery, and controversies about the standard treatment still exist. In this case report, we present a patient with idiopathic sudden sensorineural hearing loss who failed to respond to systemic and intratympanic steroid treatments but subsequently recovered after undergoing hyperbaric oxygen therapy.

No MeSH data available.


Related in: MedlinePlus